BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/27/2023 11:23:27 AM | Browse: 136 | Download: 354
 |
Received |
|
2022-11-19 12:33 |
|
Peer-Review Started |
|
2022-11-19 12:35 |
|
First Decision by Editorial Office Director |
|
2023-01-03 06:57 |
|
Return for Revision |
|
2023-01-03 06:57 |
|
Revised |
|
2023-01-16 16:22 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2023-02-10 03:37 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2023-02-10 17:30 |
|
Articles in Press |
|
2023-02-10 17:30 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-02-14 00:01 |
|
Publish the Manuscript Online |
|
2023-02-27 11:23 |
| ISSN |
1948-9366 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Fecal microbiota transplantation as potential first-line treatment for patients with Clostridioides difficile infection and prior appendectomy
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Jing-Wen Zhao, Bing Chang and Li-Xuan Sang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Li-Xuan Sang, MD, PhD, Professor, Department of Gastroenterology, Shengjing Hospital of China Medical University, No. 39 Gliding Road, Tiexi District, Shenyang 110022, Liaoning Province, China. sanglixuan2008@163.com |
| Key Words |
Clostridioides difficile infection; Appendectomy; Fecal microbiota transplantation; Intestinal microbiota; Toxic megacolon; Colectomy |
| Core Tip |
The fecal microbiota transplantation (FMT) is a universally approved treatment plan for recurrent Clostridioides difficileinfection (CDI). We believe that early FMT is a better choice for patients with CDI and prior appendectomy even if they are not diagnosed as recurrent CDI. FMT can change the composition of patients' intestinal microbiota in a lasting way to prevent worse outcomes. |
| Publish Date |
2023-02-27 11:23 |
| Citation |
Zhao JW, Chang B, Sang LX. Fecal microbiota transplantation as potential first-line treatment for patients with Clostridioides difficile infection and prior appendectomy. World J Gastrointest Surg 2023; 15(2): 303-306 |
| URL |
https://www.wjgnet.com/ 1948-9366/full/v15/i2/303.htm |
| DOI |
https://dx.doi.org/10.4240/wjgs.v15.i2.303 |
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
